After tea, coffee is next for Tata Consumer Products

FMCG major Tata Consumer Products Ltd (TCPL) is set to launch its US-based coffee brand Eight O’Clock this week in India. This is the second launch by the company in the packaged coffee segment within a month. Devika Singh brings you all the details in this piece. 

Take a look at these key events

Today:
Parliament Standing Committee on Information Technology is scheduled to hold a meeting to hear the views of Facebook India and Google India on safeguarding citizens' rights and prevention of misuse of social online news media platforms.
Tomorrow:

Mi Notebook Pro X has been teased by Xiaomi for a launch.

CoWIN couold soon be global?

Co-WIN, India's vaccine delivery tech platform, is going global as over 50 countries have expressed interest in adopting the technology. The government will create an open source version of the application to let other countries use it free of cost, said CoWIN chief RS Sharma. Swathi Moorthy brings you all the details here. 

SEBI grounds GoAir IPO for 90 days

Following a pending inquiry from its promoter Bombay Dyeing, air carrier has found its initial public offering (IPO) hopes halted by the Securities and Exchanges Board of India (SEBI) for 90 days. The IPO by GoAir, now christened GoFirst, has been kept in abeyance, the Sebi website showed on Monday. Read all about it here. 

Sachin Bansal's Navi Mutual Fund to launch the cheapest index fund

Navi Mutual Fund (MF), which is backed by Flipkart co-founder Sachin Bansal, will soon be launching the cheapest index fund -- Navi Nifty50 Index Fund. Read all about this fund, which will have a total expense ratio (TER) of 0.06 percent in its direct plan here. 

This is why the government is airlifting produce from farmers in Kashmir

Kashmiri cherries have a reputation globally. Take a look at why farmers, who have been ploughing through the pandemic are expecting to benefit from the government’s help to sell their produce after they faced challenges to produce and sell their cops amid the COVID-19 pandemic.

 

European Medicines Agency says approval for Vaxzevria does not mean Covishield will get one too

European Medicines Agency (EMA) said it would assess the manufacturing sites of the Serum Institute of India (SII) and its production processes as per the European Union (EU) law before approving the Covishield vaccine, and has made it clear that approval for Vaxzevria does not mean an approval for Covishield, too. Read all about it here.